The ODPRN conducted a drug class review on inhaled corticosteroids plus long-acting beta 2-agonists (ICS+LABA) combination products for the management of patients with asthma and chronic obstructive pulmonary disease (COPD), as well as long-acting muscarinic antagonists (LAMAs) for COPD. All three reviews were conducted between November 2013 and April 2015.
Please view the final documents for each review below.
Respiratory Reviews
Reimbursement Option Recommendations
Final Reimbursement Option Recommendations
Citizen’s Panel
Respiratory Reviews Citzen’s Panel Report
Final Publications
Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis
ICS + LABA for COPD: Final Review Documents
Final Reports and Reimbursement Options
- ICS/LABAs for COPD Final Consolidated Report
- ICS/LABAs for COPD Qualitative Report
- ICS/LABAs for COPD Environmental Scan Report
- ICS/LABAs for COPD Pharmacoepidemiology Report
- ICS/LABAs for COPD Pharmacoeconomics Report
- ICS/LABAs for COPD Systematic Review Report
Click to view the complete infographic
Click to view the complete research summary
Final Comprehensive Research Plans
- ICS/LABAs for COPD Comprehensive Research Plan (CRP) Overview
- ICS/LABAs for COPD Qualitative CRP
- ICS/LABAs for COPD Environmental Scan CRP
- ICS/LABAs for COPD Pharmacoepidemiology CRP
- ICS/LABAs for COPD Pharmacoeconomics CRP
- ICS/LABAs for COPD Systematic Review CRP
ICS + LABA for Asthma: Final Review Documents
Final Reports and Reimbursement Options
- ICS/LABAs for Asthma Final Consolidated Report
- ICS/LABAs for Asthma Qualitative Report
- ICS/LABAs for Asthma Environmental Scan
- ICS/LABAs for Asthma Pharmacoepidemiology Report
- ICS/LABAs for Asthma Phamacoeconomics Reports
- ICS/LABAs for Asthma Systematic Review Report
Click to view the complete infographic
Click to view the complete research summary
Final Comprehensive Research Plans
- ICS/LABAs for Asthma Comprehensive Research Plan (CRP) Overview
- ICS/LABAs for Asthma Qualitative CRP
- ICS/LABAs for Asthma Environmental CRP
- ICS/LABAs for Asthma Pharmacoepidemiology CRP
- ICS/LABAs for Asthma Phamacoeconomics CRP
- ICS/LABAs for Asthma Systematic Review CRP
Stakeholder Feedback
Comments from stakeholder on the draft report for ICS+LABAs for asthma
LAMAs for COPD: Final Review Documents
Final Reports and Reimbursement Options
- LAMAs for COPD Final Consolidated Report
- LAMAs for COPD Qualitative Report
- LAMAs for COPD Environmental Scan Report
- LAMAs for COPD Pharmacoepidemiology Report
- LAMAs for COPD Pharmacoeconomics Report
- LAMAs for COPD Systematic Review Report
Click to view the complete infographic
Click to view the complete research summary
Final Comprehensive Research Plans
- LAMAs for COPD Comprehensive Research Plan (CRP) Overview
- LAMAs for COPD Qualitative CRP
- LAMAs for COPD Environmental Scan CRP
- LAMAs for COPD Pharmacoepidemiology CRP
- LAMAs for COPD Pharmacoeconomics CRP
- LAMAs for COPD Systematic Review CRP
Stakeholder Feedback
- Comments from stakeholders on draft Reimbursement Option Recommendations
- Comments from stakeholder on the draft report for LAMAs for COPD
Any questions? Contact us at info@odprn.ca.